欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/0193/001
药品名称REVAXIS
活性成分
    • Diphteria toxoid 2.0 IU
    • Inactivated Polio Virus Type I 40.0 DU
    • Inactivated Polio Virus Type II 8.0 DU
    • Inactivated Polio Virus Type III 32.0 DU
    • Tetanus toxoid (T) not less than 20.0 IU
剂型Suspension for injection in pre-filled syringe
上市许可持有人Sanofi Pasteur Europe 14 Espace Henry Vallée 69007 Lyon Frankreich
参考成员国 - 产品名称Germany (DE)
Revaxis
互认成员国 - 产品名称
    • Austria (AT)
    • Belgium (BE)
      Revaxis
    • Netherlands (NL)
      Revaxis
    • Luxembourg (LU)
      Revaxis
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
      Revaxis
    • Portugal (PT)
      Revaxis
许可日期1999/10/12
最近更新日期2024/09/23
药物ATC编码
    • J07CA01 diphtheria-poliomyelitis-tetanus
申请类型
  • TypeLevel1:New Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Full Dossier Article 4.8 Di 65/65
  • TypeLevel4:Biological: Other
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase